Hem/Onc Round-up: Aspirin in Late-stage Cancer, Smoking and Cancer Screening, and more

Here are the top stories recently covered by DocWire News in the hematology/oncology section. In this edition, read about the use of aspirin in late-stage cancer, smoking and cancer screening in women, education level and mortality in multiple myeloma, and more.

Breast screening women between the ages of 40-49 attenuates the risk of dying from breast cancer, according to the findings of a study published in The Lancet Oncology.

A study which appeared in BMJ Open suggests smoking is strongly associated with the lower use of cancer screening by women.

According to the results of a new analysis published in the Journal of the National Cancer Institute, aspirin may speed up disease progression in older adults who have advanced stage cancer.

Standardized care may help address the poor outcomes in testicular cancer seen among ethnic minorities and people of low socioeconomic status, according to the findings of a study.

A study published in BMC Cancer analyzed the relationship between education level and survival in multiple myeloma (MM) and observed that patients with lower education levels may have lower survival rates.

Human papillomavirus (HPV) strain may impact cervical cancer characteristics and prognosis.

The ASCO20 Virtual Education Program took place Aug. 8–10. Here are some of the trending titles that have people talking.

Soft-tissue sarcomas and bone sarcomas account for more than 50 malignant tumor types. A study analyzed how race/ethnicity, socioeconomic status, and insurance type affect metastatic sarcoma at diagnosis.

Results from “COMBAT Trial” show pancreatic cancer patients can greatly benefit from immunotherapy.

The mortality rate for MM patients who develop COVID-19 is 29%, according to a report.

From 2013 to 2016, the mortality rate for non-small cell lung cancer in the United States significantly decreased, according to a study.